+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666480
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023, USD 18.55 billion in 2024, and is expected to grow at a CAGR of 12.02% to reach USD 36.62 billion by 2030.

Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs.

The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.

Regional Insights

Americas represents a highly developing landscape characterized by substantial investments in R&D activities by pharmaceutical and biotechnological companies and the presence of multiple research institutes. Additionally, the recent increase in patented scientific research augments the demand for research antibodies & reagents in the Americas. Significant governmental initiatives and investments to expand biotechnology research and development with advanced research equipment and tools are expected to foster the growth of the research antibodies & reagents market in Asia-Pacific.

In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The research antibodies & reagents market witnessed substantial growth in Europe, the Middle East, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

Market Trends by Segment

  • Product: Increasing popularity of antibodies for detection and quantification of target proteins
  • Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
  • Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
  • Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
  • End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation

GenScript Biotech Corporation has expanded its IVT mRNA synthesis portfolio by offering customized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. GenScript's comprehensive turnkey solution ensures that scientists receive full scientific support, from sequence design to vial delivery.

Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes

Bio-Rad Laboratories, Inc. has launched the 29th StarBright Dye, called StarBright Red 670. Additionally, they have expanded their current range by introducing 29 more antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes. The newly added targets include human and mouse antibody markers and cow, dog, and pig targets for veterinary immunology research.

Danaher to Acquire Abcam plc

Danaher Corporation has acquired Abcam plc in a cash transaction valued at approximately USD 5.7 billion. This strategic move aims to leverage Abcam plc's expertise in mapping complex diseases and accelerate the drug discovery process. This acquisition marks a significant milestone in research antibodies and reagents, ensuring the continued availability of high-quality products and services to researchers worldwide.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Alpha Teknova, Inc., Atlas Antibodies AB, Avantor, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux S.A., Cardinal Health, Inc., Cell Signaling Technology, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dovetail Genomics LLC, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GenScript Biotech Corporation, Honeywell International Inc., Illumia, Inc., ImmunoPrecise Antibodies Ltd., Leinco Technologies, Inc., LifeSpan BioSciences, Inc., LobaChemie Pvt. Ltd., Lonza Group Ltd., Merck KGaA, Omega Bio-tek, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., Thermo Fisher Scientific, Inc., Tokyo Chemical Industry Co., Ltd., and Tosoh Corporation.

This research report offers invaluable insights into various crucial aspects of the Research Antibodies & Reagents Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
5.1.1.2. Rising popularity of proteomics and genomics research
5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
5.1.2. Restraints
5.1.2.1. High cost of antibody development processes
5.1.3. Opportunities
5.1.3.1. Increasing R&D in research antibodies & reagents
5.1.3.2. Rising focus on discovering novel biomarkers
5.1.4. Challenges
5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
5.3. Market Trend Analysis
5.3.1. Increasing government investment for drug discovery coupled with robust foothold of major companies in Americas region
5.3.2. Improving healthcare infrastructure and rising investment in life sciences research in the Asia-Pacific region
5.3.3. Expanding government support for research and development in the field of genomics and strong foothold of major biotechnology companies in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Research Antibodies & Reagents Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. Reagent
7. Research Antibodies & Reagents Market, by Technology
7.1. Introduction
7.2. Enzyme-linked Immunosorbent Assay
7.3. Flow Cytometry
7.4. Immunofluorescence
7.5. Immunohistochemistry
7.6. Immunoprecipitation
7.7. Western Blotting
8. Research Antibodies & Reagents Market, by Indication
8.1. Introduction
8.2. Immunology
8.3. Infectious Diseases
8.4. Neurobiology
8.5. Oncology
8.6. Stem Cells
9. Research Antibodies & Reagents Market, by Application
9.1. Introduction
9.2. Drug Development
9.3. Genomics
9.4. Proteomics
10. Research Antibodies & Reagents Market, by End User
10.1. Introduction
10.2. Academic & Research Institutions
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology
11. Americas Research Antibodies & Reagents Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Research Antibodies & Reagents Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Research Antibodies & Reagents Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
14.3.3. Danaher to Acquire Abcam plc
14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. RESEARCH ANTIBODIES & REAGENTS MARKET RESEARCH PROCESS
FIGURE 2. RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESEARCH ANTIBODIES & REAGENTS MARKET DYNAMICS
FIGURE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. RESEARCH ANTIBODIES & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. RESEARCH ANTIBODIES & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RESEARCH ANTIBODIES & REAGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY BUFFERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FIXATIVES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FIXATIVES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROBES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROBES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY SOLVENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY SOLVENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STAINS & DYES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY GENOMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROTEOMICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 123. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 126. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 127. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 128. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 129. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 130. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 131. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 132. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 133. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 136. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 137. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 140. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 141. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 142. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 143. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 144. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 145. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 150. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 155. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 156. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 157. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 158. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 164. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 165. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 166. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 172. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 176. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 180. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 182. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 183. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 186. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 187. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 188. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 189. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 190. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 191. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 192. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 193. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 196. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 197. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 200. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 201. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 202. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 203. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 206. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 207. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 210. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 211. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 214. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 215. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 216. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 217. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 218. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 219. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 226. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 227. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 228. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 229. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 230. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 231. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 232. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 233. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 234. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 235. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 238. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 239. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 242. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 243. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 244. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 245. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 248. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 249. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 256. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 257. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 258. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 259. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 266. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 267. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 270. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 271. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 272. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 273. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 274. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 275. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 276. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 277. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 280. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 281. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 282. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 283. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 284. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 285. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 286. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 287. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 288. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 289. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 290. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 291. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 294. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 295. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 298. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 299. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 300. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 301. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 302. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 303. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 304. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 305. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 308. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 309. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 310. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 311. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2023 (USD MILLION)
TABLE 312. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2024-2030 (USD MILLION)
TABLE 313. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2023 (USD MILLION)
TABLE 314. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2024-2030 (USD MILLION)
TABLE 315. TAIWAN RESEARCH ANTIBODIES & REAGENTS MA

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Alpha Teknova, Inc.
  • Atlas Antibodies AB
  • Avantor, Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux S.A.
  • Cardinal Health, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Dovetail Genomics LLC
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GenScript Biotech Corporation
  • Honeywell International Inc.
  • Illumia, Inc.
  • ImmunoPrecise Antibodies Ltd.
  • Leinco Technologies, Inc.
  • LifeSpan BioSciences, Inc.
  • LobaChemie Pvt. Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Rockland Immunochemicals, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Sino Biological, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Tosoh Corporation

Methodology

Loading
LOADING...

Table Information